EQS-Adhoc

    157 Aufrufe 157 0 Kommentare 0 Kommentare

    CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO

    Für Sie zusammengefasst
    • New CEO appointed: Prof. Dr. Daniel Gotthardt.
    • Michael Rauch's contract terminated early, effective Aug 31.
    • Gotthardt has been with the company since 2023.

    EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Personnel
    CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO

    31-Jul-2024 / 18:36 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO

    Anzeige 
    Handeln Sie Ihre Einschätzung zu CompuGroup Medical!
    Long
    11,78€
    Basispreis
    1,60
    Ask
    × 8,07
    Hebel
    Zum Produkt
    Short
    15,19€
    Basispreis
    1,88
    Ask
    × 7,20
    Hebel
    Zum Produkt
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Koblenz, Germany. The general partner of CompuGroup Medical SE & Co. KGaA (the “Company”) (ISIN: DE000A288904 | WKN: A28890) announces that the Administrative Board of CompuGroup Medical Management SE and CEO Michael Rauch decided today in mutual agreement to terminate his contract prematurely as of August 31, 2024, including resignation from his position as Managing Director and member of the Administrative Board of CompuGroup Medical Management SE as well as of the Joint Committee of the Company.

    Effective as of September 1, 2024, the Administrative Board of CompuGroup Medical Management SE appoints Prof. (apl.) Dr. med. Daniel Gotthardt as Managing Director and CEO. Daniel Gotthardt has been Senior Vice President and Chief Medical Officer of the Company since the beginning of 2023. He has also been a member of the Supervisory Board of former CompuGROUP Holding AG and CompuGroup Medical SE since 2003, and has been a member of the Administrative Board of CompuGroup Medical Management SE since 2020.

     

     

     



    End of Inside Information

    31-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com

    Language: English
    Company: CompuGroup Medical SE & Co. KGaA
    Maria Trost 21
    56070 Koblenz
    Germany
    Phone: +49 (0)160 3630362
    Fax: +49 (0)261 8000 3200
    E-mail: investor@cgm.com
    Internet: www.cgm.com
    ISIN: DE000A288904
    WKN: A28890
    Indices: SDAX, TecDAX
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1958515

     
    End of Announcement EQS News Service

    1958515  31-Jul-2024 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1958515&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e 

    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Verfasst von EQS Group AG
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    EQS-Adhoc CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Personnel CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO 31-Jul-2024 / 18:36 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the …